Status:
COMPLETED
Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia
Lead Sponsor:
Jaeb Center for Health Research
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Amblyopia
Eligibility:
All Genders
3-7 years
Phase:
PHASE3
Brief Summary
The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with minimal patch...
Detailed Description
Amblyopia is the most common cause of monocular visual impairment in both children and young and middle-aged adults. Patching has been the mainstay of amblyopia therapy. It is generally held that the ...
Eligibility Criteria
Inclusion
- Patients must be less than 7 years of age with the original cause of amblyopia as strabismus or anisometropia.
- Visual Acuity in the amblyopic eye must be between 20/40 and 20/80.
- Visual acuity in the sound eye of 20/40 or better.
- There must be at least 3 lines of acuity difference between the two eyes.
Exclusion
- Patching treatment (other than spectacles) within six months prior to enrollment and other amblyopia treatment of any type used within one month prior to enrollment.
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2002
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT00094679
Start Date
May 1 2001
End Date
September 1 2002
Last Update
September 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilmer Eye Institute
Baltimore, Maryland, United States, 21287-9028